Acioly Luiz Tavares Lacerda
Professor of Psychiatry at the Federal University of São Paulo (UNIFESP)
Data updated
Research Footprint
Acioly Luiz Tavares Lacerda appears in 6 tracked papers (2017–2025), most studied alongside Ketamine and Esketamine, across Depressive Disorders, Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).
Most-cited paper: Intravenous arketamine for treatment-resistant depression: open-label pilot study (257 citations).
Frequent co-authors: Gustavo Leal, Gerard Sanacora and Colleen Loo.
Background & Research
Acioly Luiz Tavares de Lacerda is a Brazilian psychiatrist and academic associated with UNIFESP, where he has been linked to the Department of Psychiatry and the PRODAF affective disorders program. His research has focused on ketamine, esketamine, and other rapid-acting interventions for depression, including treatment-resistant depression and suicidal ideation.
Key Impact
He is a leading Brazilian psychiatrist and ketamine/esketamine researcher whose clinical studies helped shape evidence on rapid-acting treatments for treatment-resistant depression and suicidality.
Collaboration Network
9 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Acioly Luiz Tavares Lacerda is associated with.